Christophe Girardet
-
- Monoclonal and Polyclonal Antibodies Research 7
- Radiopharmaceutical Chemistry and Applications 4
- Pathology and Forensic Medicine top 10%
- Autoimmune Bullous Skin Diseases 3
- Genetics top 10%
-
- Vascular Tumors and Angiosarcomas 2
- CAR-T cell therapy research 2
-
- Glycosylation and Glycoproteins Research 4
-
- Gastrointestinal disorders and treatments 2
-
- Eosinophilic Disorders and Syndromes 2
Christophe Girardet
25 papers receiving 826 citations
Peers
Comparison fields: 5 of 84
- Radiology, Nuclear Medicine and Imaging 336
- Pathology and Forensic Medicine 195
- Genetics 93
- Immunology 157
- Oncology 200
Countries citing papers authored by Christophe Girardet
This map shows the geographic impact of Christophe Girardet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Girardet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Girardet more than expected).
Fields of papers citing papers by Christophe Girardet
This network shows the impact of papers produced by Christophe Girardet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Girardet. The network helps show where Christophe Girardet may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christophe Girardet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 9 | |
| 2 | 2012 | 3 | |
| 3 | 2004 | 41 | |
| 4 | 2003 | 69 | |
| 5 | 2002 | 3 | |
| 6 | 2002 | 40 | |
| 7 | 2002 | 10 | |
| 8 | 2001 | 100 | |
| 9 | 2001 | 1 | |
| 10 | 2001 | 21 | |
| 11 | 2000 | 9 | |
| 12 | 1999 | 5 | |
| 13 | 1996 | 113 | |
| 14 | 1993 | 4 | |
| 15 | 1984 | 8 | |
| 16 | 1984 | 19 | |
| 17 | 1983 | 22 | |
| 18 | 1983 | 2 | |
| 19 | 1983 | 52 | |
| 20 | 1981 | 274 |
About Christophe Girardet
Christophe Girardet is a scholar working on Dermatology, Radiology, Nuclear Medicine and Imaging, Immunology, Pathology and Forensic Medicine and Oncology, having authored 25 papers that have together received 887 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Glycosylation and Glycoproteins Research (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Autoimmune Bullous Skin Diseases (3 papers), Vascular Tumors and Angiosarcomas (2 papers), CAR-T cell therapy research (2 papers), Gastrointestinal disorders and treatments (2 papers) and Eosinophilic Disorders and Syndromes (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (336 citations), Pathology and Forensic Medicine (195 citations), Genetics (93 citations), Immunology (157 citations) and Oncology (200 citations). Christophe Girardet has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include S Carrel, William H. Walker, Joel F. Habener, Magali Schreyer, J P Mach, C. Berche, Roberto S. Accolla, J Ritschard, M. Forni and Franz Buchegger. Their work appears in journals such as New England Journal of Medicine, The Journal of Immunology, Gene, International Journal of Radiation Oncology*Biology*Physics and Clinical Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.